Name: Achromobacter xylosoxidans (ex Yabuuchi and Ohyama 1971) Yabuuchi and Yano 1981 emend. Yabuuchi et al. 1998
Synonym(s): Achromobacter xylosoxidans subsp. xylosoxidans (ex Yabuuchi and Ohyama 1971) Yabuuchi et al. 1998
Alcaligenes denitrificans subsp. xylosoxydans (Yabuuchi and Yano 1981) Kersters and De Ley 1984Alcaligenes xylosoxidans subsp. xylosoxidans (Yabuuchi and Yano 1981) Kiredjian et al. 1986
Alcaligenes xylosoxidans (Yabuuchi and Yano 1981) Kiredjian et al. 1986
DSM No.: 26089
Other collection no.
or WDCM no.: CCUG 45179
Isolated from: human sputum of a cystic fibrosis patient Country: Austria
Wien Date of sampling: before 22.06.2012
Nagoya Protocol Restrictions: There are NO known Nagoya Protocol restrictions for this strain.
History: <- CCUG <- A. Makristathis Cultivation conditions: Medium 220 , 30°C
orMedium 693 , 37°C
Incubation time: 1-2 days
Complete DSMZ Media ListSummary and
additional information: <- CCUG <- A. Makristathis. Human sputum of a cystic fibrosis patient; Austria, Wien. (Medium 220, 30°C or Medium 693, 37°C).
For detailed information: BacDive - The Bacterial Diversity MetadatabaseRisk group: 2 (classification according to German TRBA)
Restrictions: Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
Supplied as:Delivery formPrices
Freeze Dried80,- ?
Active culture on request185,- ?
DNA120,- ?
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
Note: Freight charges for Risk Group 2 microorganisms will apply.Other cultures: All DSMZ cultures of the species
DSM26089
